OBJECTIVES The purpose of this study was to evaluate the plethysmographic signal-derived oxygen desaturation index (ODI) as an inpatient screening strategy to identify sleep-disordered breathing (SDB) in patients with congestive heart failure (CHF).
To improve on early identification of SDB in hospitalized HF patients, we undertook a study of photoplethysmography signal recording for screening SDB in hospitalized patients with HF. Photoplethysmography signal recording is a simple, low-cost tool to determine the oxygen desaturation index (ODI) (oxygen desaturations per hour), and it is readily available in the hospital. In the outpatient setting, ODI has been shown to correlate with apnea hypopnea index (AHI) (apnea hypoxia episodes per hour) derived from PSG (11, 12) . However, data on the usefulness of overnight inpatient ODI for early diagnosis of SDB in patients admitted for congestive heart failure is lacking. To evaluate the value of a screening strategy in patients admitted with ADHF (acute decompensated heart failure), our study combined symptom assessment, sleep evaluation, and inpatient ODI to identify SDB, using PSG-derived AHI to verify the diagnosis. heavy snoring, tiredness, observed apneas, hypertension, body mass index [BMI] >35 kg/m 2 , age >50 years, neck circumference >40 cm, and male sex (13, 14) . For patients who exhibited sleep-related symptoms (positive for $3 items on the questionnaire), the admitting team was notified and a sleep consult was recommended. Patients were not screened during weekends.
METHODS

This is
Patients were also excluded if they had an established diagnosis of sleep apnea and were currently on therapy. Some patients also refused screening. The iterative expectation-maximization (EM) method was used to account for missing values (20) .
Statistical significance was defined as p < 0.05. SAS version 9.3 (SAS Institute, Cary, North Carolina) was used for all analyses. Figure 1 shows patient recruitment. A total of 282 patients who were admitted with decompensated CHF were screened during the time frame of this study. The mean age of this cohort was 63 AE 12 years, and 159 (56%)
RESULTS
were male. The mean BMI was 36 AE 9.3 kg/m 2 . All 282 patients were screened for SDB using the STOP-BANG questionnaire, and 246 tested as high risk (87%) for SDB. Values are n (%). *Missing values imputed using the expectation-maximization algorithm (10 simulations; average imputational efficacy $98%). †Body mass index (BMI) was computed as mass in kilograms divided by height in meters squared.
ACE ¼ angiotensin-converting enzyme; AHI ¼ apnea-hypopnea index; COPD ¼ chronic obstructive pulmonary disease; IQR ¼ interquartile range; NA ¼ not applicable; ODI ¼ oxygen desaturation index; PSG ¼ polysomnography; STOP-BANG ¼ questionnaire of heavy snoring, tiredness, observed apneas, hypertension, body mass index >35 kg/m 2 , age >50 years, neck circumference >40 cm, and male sex. at the center and suggests that it may not be very discriminatory in this setting. But, although the STOP-BANG questionnaire may have low specificity, in our model it served as an effective awareness tool among house staff and admitting physicians. In addition, it can be self-administered (14) . Also, the screening pathway is obstructive sleep apnea specific, and central sleep apnea might be under-represented.
Our novel pathway appears to have a high yield in terms of finding patients with significant sleep Table 1 .
disordered breathing, but this study cannot evaluate the overall effectiveness of this approach in all admitted patients with AHF.
Our study was also limited by the number of patients who subsequently obtained a PSG that was available for analysis. It is worth noting, however, that the baseline characteristics of the patients for which a PSG result was available were not significantly different than the overall population with a positive STOP-BANG (Table 1) . Finally, due to the nature of the study design, the investigators were unable to evaluate potential false negatives in ODI <5. As the study was conducted at a tertiary care hospital with a committed heart failure program, the diagnosis was provided by a heart failure specialist, and we did not collect detailed HF parameters. 
CONCLUSIONS
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